CPHI_OUT_1 [2025-04-28 07:01:05 -0400] 5955 Bytes | 1579 tokens | Cum: 1579 tkns (19.74% of 8k)
==========================================================================

Listen up, partner—it's 7:01 AM on Mon Apr 28, 2025, and I’m revved up about China Pharma (CPHI), climbing from $1.87 to $1.98. This stock is buzzing big-time—do we have a hidden gem, or a flash in the pan? Help me sift through the data!

--- COMPANY PROFILE ---
Company: China Pharma (CPHI)
IPO: 2002-04-14 (23 Years Ago)
Market Cap: $4,717,998
Shares Outstanding: 19,250,000
Industry: PHARMACEUTICAL PREPARATIONS
Exchange: XASE
Description: China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.

Here’s a list of headlines for China Pharma:

Apr-04-25 04:05PM - China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock Split
Dec-18-24 08:30AM - China Pharma Holdings, Inc. Completes Full Redemptions Under Convertible Note Agreement with Streeterville
Dec-13-24 08:00AM - China Pharma Announces the Entry of "At-The-Market" Equity Offering
Aug-19-24 08:00AM - China Pharma Holdings, Inc. expects to launch its Dry Eye Disease Therapeutic Device in the first quarter of 2025
Feb-23-24 04:05PM - China Pharma Holdings Inc. Announces 1-for-5 Reverse Stock Split
Nov-29-23 08:00AM - China Pharma Holdings, Inc. Announced the Completion of Third Party Testing of Dry Eye Disease Therapeutic Device
Aug-23-23 07:34PM - Is China Pharma Holding (CPHI) A Hidden Gem or A Value Trap?
Aug-09-23 08:30AM - China Pharma's Candesartan Hypertension Product Passes the Quality and Efficacy Consistency Evaluation of Generic Drugs
Feb-24-23 04:05PM - China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock Split
Dec-28-22 08:00AM - China Pharma Holdings, Inc. Announced the Launch of N95 Medical Protective Mask
Dec-15-22 08:00AM - China Pharma Holdings, Inc. Announced that several products are included in the Catalogue of Medicines for People Infected with COVID-19
Dec-05-22 08:00AM - China Pharma Holdings, Inc. Announced the Acquisition of Dry Eye Disease Therapeutic Device Project
Dec-02-22 04:10PM - China Pharma Announces Receipt of Noncompliance Notice from NYSE American
Oct-01-22 10:05PM - China Pharma Announces Receipt of Notification of NYSE American Listing Deficiency
Jul-18-22 08:00AM - China Pharma Announced the Submission of a Plan of Compliance to NYSE American
Jun-22-22 05:00PM - China Pharma Announces Receipt of Noncompliance Notice from NYSE American
Mar-31-22 08:00AM - China Pharma Holdings, Inc. Reports Fiscal Year 2021 Financial Results
Nov-12-21 04:30PM - China Pharma Holdings, Inc. Reports Third Quarter 2021 Financial Results
Aug-13-21 04:30PM - China Pharma Holdings, Inc. Reports Second Quarter 2021 Financial Results
Aug-05-21 09:00AM - China Pharma's Candesartan Hypertension Product Passes Bioequivalence Tests and the Company Plans to Apply for NMPA Approval
Jun-09-21 08:00AM - China Pharma to Launch Highly Purified NMN+PQQ Product
May-14-21 04:30PM - China Pharma Holdings, Inc. Reports 33% YoY Increase in First Quarter 2021 Revenue

Prior AI Reports for CPHI:
1. 2025-04-02 – Score: 40 – Target: 0.3000 – Highs: 0.2604 / 0.2645 / 0.24
company-struggles-amid-declining-sales-and-assets-potential-for-modest-recovery

(Note: Highs = Same day / 2nd day / 3rd day)

Here's another list of headlines with menu handles.
I will deliver the full text of the following stories when you say their handle.
Just say, for example, B1, B2, etc.

B1 - 2024-01-29T12:56:17Z - Why ZIM Integrated Shipping Services Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
B2 - 2023-12-26T13:00:58Z - Why Sentage Holdings Shares Are Trading Lower By 5%; Here Are 20 Stocks Moving Premarket
B3 - 2023-11-29T19:02:04Z - Why Patterson Companies Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
B4 - 2023-11-29T14:48:31Z - Nasdaq Surges Over 100 Points; US Economy Expands Faster Than Expected
B5 - 2023-08-23T17:02:53Z - Why Grab Holdings Are Trading Higher By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
B6 - 2023-08-23T12:34:21Z - Why AMC Entertainment Shares Are Trading Lower By 21%; Here Are 20 Stocks Moving Premarket

==============
-> THE ROLE FOR AI:
==============

1) You are the **AI analyst-investigator**, and this interaction represents a full **due diligence session** for China Pharma (CPHI).
Due diligence includes financial data, insider trading, relevant news, and any SEC filings — and may extend beyond classic fundamentals.
Your task is to identify whether this stock has momentum and potential.

2) I am **ScanScor**, a unified report generator that archives this session as part of our real-time diligence record.

3) You will request information by referencing documents by their code.

4) As the analysis proceeds, your are encouraged to review documents until you feel confident in your judgment.
After seeing 3 sets of news articles, SEC docs, and financials, you'll be prompted to return some data pairs.

5) News articles, SEC filings, and key metrics will be revealed in subsequent prompts.

Stay focused. Gather evidence. Continue until your conclusions are clear.
Restrict all your responses to just 3 tokens until the summary and data pairs at the end.

NEXT: Request a document with its reference code(s), such as:
- `B1`, `B2`, `B3`, etc.
- To load a new set of information and menu options, reply with: `NEX`

CPHI_OUT_3 [2025-04-28 07:01:06 -0400] 985 Bytes | 306 tokens | Cum: 1887 tkns (23.59% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-04-16T13:18:00Z - Pre-market Movers: ICAD, TGL, OST, SBEV, HXHX....
A2 - 2025-04-07T17:05:50Z - 12 Health Care Stocks Moving In Monday's Intraday Session - Aditxt (NASDAQ:ADTX), Alumis (NASDAQ:ALM...
A3 - 2025-04-07T16:35:55Z - Crude Oil Down 2%; Chanson International Shares Spike Higher - ReAlpha Tech (NASDAQ:AIRE), Chanson I...
A4 - 2025-04-07T14:42:37Z - Nasdaq Surges Over 400 Points; China Pharma Shares Plummet - ReAlpha Tech (NASDAQ:AIRE), Antelope En...
A5 - 2025-04-07T09:43:39Z - US Stock Futures Drop Following Massive Tariff-Induced Selloff: Experts Warn Of A Brewing 'Great Dep...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

CPHI_OUT_5 [2025-04-28 07:01:07 -0400] 1181 Bytes | 431 tokens | Cum: 2320 tkns (29.00% of 8k)
==========================================================================

Showing A1 (chunk 1 of 2): A1:
**Pre-market Movers: ICAD, TGL, OST, SBEV, HXHX.**Date: 2025-04-16Source: {'uri': 'finanznachrichten.de', 'dataType': 'news', 'title': 'FinanzNachrichten.de'}URL: https://www.finanznachrichten.de/nachrichten-2025-04/65136771-pre-market-movers-icad-tgl-ost-sbev-hxhx-020.htmOTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.45 A.M. ET).

In the Green

iCAD, Inc. (ICAD) is up over 67% at $3.23. Treasure Global Inc. (TGL) is up over 53% at $3.20. Splash Beverage Group, Inc. (SBEV) is up over 26% at $3.57. ESSA Pharma Inc. (EPIX) is up over 12% at $1.83. China Pharma Holdings, Inc. (CPHI) is up over 12% at $1.65. ATIF Holdings Limited (ZBAI) is up over 12% at $1.10. NioCorp Developments Ltd. (NB) is up over 10% at $3.20. Comstock Inc. (LODE) is up over 8% at $2.10. Innventure, Inc. (INV) is up over 7% at $3.61. SAG Holdings

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

CPHI_OUT_7 [2025-04-28 07:01:07 -0400] 1007 Bytes | 356 tokens | Cum: 2678 tkns (33.48% of 8k)
==========================================================================

Showing A1 (chunk 2 of 2): Limited (SAG) is up over 7% at $1.16. Lifetime Brands, Inc. (LCUT) is up over 13% at $4.40.

In the Red

Ostin Technology Group Co., Ltd. (OST) is down over 29% at $2.25. Haoxin Holdings Limited (HXHX) is down over 20% at $2.46. Cricut, Inc. (CRCT) is down over 16% at $4.01. Classover Holdings, Inc. (KIDZ) is down over 13% at $1.20. Click Holdings Limited (CLIK) is down over 11% at $2.35. China Yuchai International Limited (CYD) is down over 8% at $15.28. Eve Holding, Inc. (EVEX) is down over 8% at $3.49. Ensysce Biosciences, Inc. (ENSC) is down over 7% at $2.08. Coda Octopus Group, Inc. (CODA) is down over 6% at $6.82.

Copyright(c) 2025 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX© 2025 AFX News

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

CPHI_OUT_9 [2025-04-28 07:01:10 -0400] 1081 Bytes | 277 tokens | Cum: 2957 tkns (36.96% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

S1 - 2025-04-04 8-K Item 7.01 Regulation FD Disclosure

On April 4, 2025, China Pharma Holdings, Inc. (the Company) issued a press release, included herewith as Exhibit 99.1, announcing that it expects to implement a 1-for-10 reverse stock split effective Tuesday, April 15, 2025, that every 10 shar...

S2 - 2025-03-31 10-K ITEM 7. MGT DISC & ANALYSIS OF FIN COND & RESULTS OF OPER.

The statements contained in this report with respect to our financial condition, results of operations and business that are not historical facts are forward-looking statements. Forwa...

S3 - 2025-03-31 10-K ITEM 7. MGT DISC & ANALYSIS OF FIN COND & RESULTS OF OPER.

The statements contained in this report with respect to our financial condition, results of operations and business that are not historical facts are forward-looking statements. Forwa...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

CPHI_OUT_11 [2025-04-28 07:01:11 -0400] 1181 Bytes | 297 tokens | Cum: 3256 tkns (40.70% of 8k)
==========================================================================

Showing S1 (chunk 1 of 2): S1:
Item 7.01 Regulation FD Disclosure

On April 4, 2025, China Pharma Holdings, Inc. (the Company) issued a press release, included herewith as Exhibit 99.1, announcing that it expects to implement a 1-for-10 reverse stock split effective Tuesday, April 15, 2025, that every 10 shares of the pre-split common stock of the Company, par value $0.001 per share, will be converted into one post-split common stock of the Company, par value $0.001 per share, with trading to begin on a split-adjusted basis at the market open on that day.

The information disclosed under this Item 7.01, including Exhibit 99.1 hereto, is being furnished and shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be deemed incorporated by reference into any filing made under the Securities Act of 1933, except as expressly set forth by specific reference in such fili

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

CPHI_OUT_13 [2025-04-28 07:01:11 -0400] 289 Bytes | 86 tokens | Cum: 3344 tkns (41.80% of 8k)
==========================================================================

Showing S1 (chunk 2 of 2): ng....

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

CPHI_OUT_15 [2025-04-28 07:01:16 -0400] 5910 Bytes | 1573 tokens | Cum: 4919 tkns (61.49% of 8k)
==========================================================================

This is our set of metrics for China Pharma.
Please analyze the numbers.

+---------------------+----------------------+------------------------+------------------------+
| Volume: 379,757 | Perf Month: -29.11% | Option/Short: No / Yes | Sales Y/Y TTM: -35.41% |
+---------------------+----------------------+------------------------+------------------------+
| Avg Volume: 107.40K | Perf Quarter: -7.88% | Short Float: 0.42% | ROE: -61.58% |
+---------------------+----------------------+------------------------+------------------------+
| Rel Volume: 3.68 | Index: - | Short Ratio: 0.06 | ROI: -50.82% |
+---------------------+----------------------+------------------------+------------------------+
| RSI (14): 50.20 | Market Cap: 6.10M | Short Interest: 0.01M | Sales Surprise: - |
+---------------------+----------------------+------------------------+------------------------+
| ATR (14): 0.33 | Shs Outstand: 3.26M | Beta: 0.89 | EPS Surprise: - |
+---------------------+----------------------+------------------------+------------------------+
| SMA20: 4.20% | Shs Float: 1.59M | Sales Q/Q: -47.25% | P/E: - |
+---------------------+----------------------+------------------------+------------------------+
| SMA50: -12.64% | Inst Own: 0.53% | Sales past 5Y: -15.33% | Earnings: - |
+---------------------+----------------------+------------------------+------------------------+
| SMA200: -13.39% | Insider Own: 51.28% | Employees: 231 | |
+---------------------+----------------------+------------------------+------------------------+
| Perf Week: 24.95% | Insider Trans: 0.00% | Debt/Eq: 0.45 | |
+---------------------+----------------------+------------------------+------------------------+

The next section covers any insider trading by China Pharma officers or majority shareholders (if available).

[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 5544620.0, 'unit': 'USD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': -4744146.0, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 1.87
Average Volume: 136739.67
30-Day High: 2.631
30-Day Low: 1.3

[Detailed Financials: Q3 2024]
- Total Assets: $13,465,610.00
- Total Liabilities: $6,937,361.00
- Total Equity: $6,528,249.00
- Current Assets: $3,738,977.00
- Current Liabilities: $4,760,209.00

[Income Statement: Q3 2024]
- Revenue: $1,100,152.00
- Net Income: $-1,117,911.00
- Gross Profit: $-519,649.00
- Operating Income: $-1,085,257.00
- Earnings Per Share (EPS): -0.06

[Cash Flow Statement: Q3 2024]
- Net Cash Flow: $-30,889.00

[Detailed Financials: Q2 2024]
- Total Assets: $14,261,233.00
- Total Liabilities: $6,852,711.00
- Total Equity: $7,408,522.00
- Current Assets: $3,972,978.00
- Current Liabilities: $4,712,035.00

[Income Statement: Q2 2024]
- Revenue: $924,943.00
- Net Income: $-1,438,130.00
- Gross Profit: $-1,015,386.00
- Operating Income: $-1,391,521.00
- Earnings Per Share (EPS): -0.09

[Cash Flow Statement: Q2 2024]
- Net Cash Flow: $-672,262.00
==== END OF FINANCIAL REPORT ====

You are now requested to write a summary analysis of China Pharma (CPHI).

Please complete the report using the exact format:
FIELD[value]

1) BRIEF_SUMMARY[]
One well-worded paragraph summarizing your findings about China Pharma.

2) MARKET_SCORE[]
This conversation was initiated because CPHI is currently experiencing upward price and volume movement.
Estimate a number between 1–100 based on the likelihood of a continued upward price move for CPHI.
Weigh relevant data — news, filings, fundamentals, and metrics — and assign appropriate weight.

3) PRICE_TARGET[]
Suggest a price, based on all prior evidence and past price behavior, CPHI could reach in the current or upcoming trading sessions (1–5 days).
For example, if you expect CPHI to increase 50% from its current price of $0.00, say: PRICE_TARGET[0.0]

4) AI_RPT_HEADLINE[]
Write a thought-provoking 8–12 word headline summarizing this report.

5) SQUEEZE_POTENTIAL[]
Give a score from 1 to 100 representing the potential for this stock to become an active short squeeze play.
Be honest and unbiased. Consider short interest/float, price movement, volume, news strength, and volatility potential.

6) TAGS[]
List 3–6 comma-separated tags (e.g., biotech, earnings beat, squeeze setup)

7) STOCK_TYPE[]
Choose the most accurate classification: growth, value, turnaround, hype, squeeze, dividend, speculative, or other.

8) PRIMARY_CATALYST[]
e.g., earnings report, FDA approval, partnership, etc.

9) SENTIMENT[]
bullish, bearish, neutral, or mixed

10) IMPROVEMENT_SUGGESTION[]
If you believe some key info was missing, state what would have significantly improved your analysis of China Pharma.

11) ETHICAL_RATING[]
Rate China Pharma’s alignment with long-term shareholder interests, using a letter grade from A (high alignment) to F (low alignment).
Base this on actions such as insider buying/selling, share dilution, follow-through on public statements, and compensation practices.

12) UPCOMING_CATALYST[]
Specify any upcoming events you expect would be a catalyst affecting the share-price of China Pharma.
Provide any reasons you can use to support it.

Return only: FIELD[value] for each of the above 12 questions.
Respond with all data pairs. Take your best guess if you have to, but don't leave blank items.
Do not explain your answers. Return only the required fields in the exact format shown.

Finally, thank you for participating!

CPHI_IN_17 [2025-04-28 07:01:17 -0400] 126 Bytes | 29 tokens | Cum: 5128 tkns (64.10% of 8k)
==========================================================================

====================================
[2025-04-28 07:01:17] # Analysis Completed
Elapsed Time: 12.60 seconds